Biohaven is proposing troriluzole for the treatment of spinocerebellar ataxia, a group of rare, genetic diseases that lead to ...
Developing high-yielding, nutritious and climate-resilient crops is vital to safeguard the future of global food production.
4h
Cathie Wood Offloads Millions of Biotech Shares, Ramps Stake in Veracyte Days Before Earnings Beat
Cathie Wood's Ark Invest sold shares of five biotech and healthcare companies in recent trades. She also offloaded over 1.1 ...
Patent expands MEAI’s global intellectual property protection as Clearmind advances clinical development and commercialization plans Vancouver, Canada, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Clearmind ...
NEW YORK – Azalea Therapeutics launched on Tuesday, having raised $82 million in seed and Series A financing to develop in vivo genetic medicines for cancer and autoimmune conditions using its ...
Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...
Colossal Biosciences, the Dallas-based biotechnology company known for its bold mission to resurrect extinct species such as ...
Scilex Holding Company ("Scilex" or the "Company") (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing ...
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
Biotech raises $540M from DRW, ARK Invest for Canton Coin treasury. Shares surge 120% on Super Validator plans.
Pichia pastoris is emerging as a versatile, efficient alternative for protein production, bridging microbial and mammalian expression systems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback